查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1951276

人工神經導管市場－全球產業規模、佔有率、趨勢、機會與預測：材料、神經、電活性、應用、最終用途、地區和競爭格局，2021-2031年

Artificial Nerve Conduits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Material, By Nerve, By Electroactivity, By Application, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球人工神經導管市場預計將從 2025 年的 28.5 億美元成長到 2031 年的 41.6 億美元，複合年成長率為 6.51%。

這些由生物來源材料或合成聚合物製成的生物工程管狀植入，透過橋接斷裂的周邊神經缺損並引導神經軸突再生發揮作用。市場成長的主要促進因素是全球範圍內因車禍和職業危害導致的創傷性損傷發生率不斷上升，這迫切需要一個有效的神經修復方案。此外，老年人口的成長（老年人易患退化性神經病變）以及自體神經移植的局限性（例如供體部位併發症風險和組織短缺）進一步促使外科醫生採用這些現成的再生替代方案。

市場概覽
預測期 2027-2031
市場規模：2025年 28.5億美元
市場規模：2031年 41.6億美元
複合年成長率：2026-2031年 6.51%
成長最快的細分市場 合成
最大的市場 北美洲

先進導管系統的高成本和嚴格的報銷政策給市場擴張帶來了巨大挑戰，限制了注重成本地區的患者獲得此類治療的機會。為了佐證創傷對市場需求的影響，美國國家安全委員會發布了2025年的初步數據，顯示2024年美國約有44,680人死於車禍。這項統計數據反映了高速交通事故持續帶來的沉重負擔，而這類事故往往會導致複雜的神經損傷，需要手術修復。

市場促進因素

3D列印和生物可吸收導管技術的進步正在從根本上重塑市場格局，克服了傳統自體移植的局限性，例如組織來源有限和供體部位併發症。積層製造技術的創新使得製造具有精確微結構的導管成為可能，這些導管能夠模擬天然細胞外基質，促進軸突導向和神經殘端間的再生。這些現代支架經過精心設計，可完全生物吸收，無需二次手術取出，並能減少長期發炎反應。例如，2025年8月發表在PubMed Central上的一項研究表明，在小鼠模型中，3D列印的水凝膠導管實現了與標準自體移植相當的功能性運動神經再生，這表明這些合成材料可能成為一種可行的標準治療方法。

創傷性周邊神經損傷的發生率不斷上升，這主要是由高衝擊力機動車事故、職場危險因素和複雜手術等醫源性損傷造成的，也是推動該領域發展的主要因素。日益加重的負擔使得人們迫切需要可靠的、現成的修復方案來彌補神經缺損，尤其是在無法進行無張力修復的情況下。 2025年12月，ResearchGate的一項調查報告顯示，手術全期周邊神經損傷的發生率為每10萬例手術住院患者中有14.6例，凸顯了對有效再生醫學介入措施的巨大需求。這種臨床需求正在推動行業領先企業的財務成長。 2025年2月，Axogen公佈了2024會計年度全年營收為1.873億美元，年增17.8%，這主要得益於其先進神經修復技術的日益普及。

市場挑戰

全球市場成長受到先進導管系統高成本和嚴格的報銷政策的顯著阻礙。預算緊張的醫療系統往往優先考慮成本控制，因此，當有更便宜的替代方案（例如直接縫合或自體移植）時，他們往往不願意採用昂貴的生物工程植入。在一些地區，保險系統將這些器械歸類為「研究性」或「選擇性」器械，導致覆蓋範圍有限，從而加劇了這種財務壓力。最終，醫院和病患被迫承擔這些費用，使得只有一小部分人能夠獲得這些器械。

這種經濟差距嚴重限制了現成神經修復方案的廣泛商業性應用。根據美國整形外科醫師協會2024年的數據，神經導管修復手術的總費用中位數約為25,717美元，遠高於標準的第一期修復技術。如此高昂的手術費用阻礙了其大規模應用，實際上將市場限制在資金雄厚的醫療機構，並阻止了該行業在全球範圍內取代傳統的、成本更低的治療方法。

市場趨勢

市場正從被動神經橋接轉向主動生物修復，後者將神經營養因子融入導管設計中。製造商正優先研發能夠生物刺激軸突再生的裝置，以克服惰性導管在斷裂損傷中的功能限制。隨著支付方認知到功能恢復比簡單的結構修復更具長期價值，這種向生物活性解決方案的轉變正獲得商業性支持。為了反映這一趨勢，Axogen於2025年10月宣布，其神經修復產品線的保險覆蓋範圍已擴大至2025年約1810萬名患者，這表明市場對先進再生演算法的需求日益成長。

同時，天然-合成混合複合材料的出現，結合了聚合物的機械耐久性和生物基質的生物相容性，正在最佳化植入的有效性。與容易引起發炎的第一代合成材料或缺乏剛性的純生物材料不同，新一代複合材料，例如水凝膠增強細胞外基質，能夠提供平衡的微環境，既支持細胞黏附，又能防止細胞崩壞。這項技術革新正在提升領先創新企業的財務表現。 2025年10月，Axogen公司宣布第三季營收達6,010萬美元，年增23.5%，主要得益於該公司先進的混合生物系統。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球人工神經導管市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依材料分類（合成材料、生物來源、混合材料）
    • 依神經類型（接觸引導、通道引導、微地形引導）
    • 依電活性（電活性、非電活性）分類
    • 依應用領域（周邊神經修復、脊髓損傷修復、顱神經修復）
    • 依最終用途（醫院、診所、研究機構）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美人工神經導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲神經導管人工血管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區人工神經導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲人工神經導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲人工神經導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球人工神經導管市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Axogen Corporation
  • Axonics, Inc.
  • Cytograft Tissue Engineering
  • FibroGen, Inc.
  • Eton Bioscience Inc.
  • Kerimedical SA
  • Synaptive Medical Inc.
  • Stryker Corporation
  • Newrotex Ltd
  • Integra LifeSciences Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27595

The Global Artificial Nerve Conduits Market is projected to expand from USD 2.85 Billion in 2025 to USD 4.16 Billion by 2031, registering a CAGR of 6.51%. These bioengineered tubular implants, crafted from biological materials or synthetic polymers, are designed to bridge defects in severed peripheral nerves by guiding axonal regeneration across gaps. Market growth is primarily fueled by the increasing global incidence of traumatic injuries from vehicular accidents and occupational hazards, which demand effective nerve restoration solutions. Additionally, the growing geriatric population, which is prone to degenerative neuropathies, along with the limitations of autologous nerve grafts-such as donor site morbidity and tissue scarcity-further encourages surgeons to utilize these off-the-shelf regenerative alternatives.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.85 Billion
Market Size 2031USD 4.16 Billion
CAGR 2026-20316.51%
Fastest Growing SegmentSynthetic
Largest MarketNorth America

High costs associated with advanced conduit systems and restrictive reimbursement policies pose a significant challenge to market expansion, limiting patient access in cost-conscious regions. Underscoring the impact of trauma on market demand, the National Safety Council reported preliminary data in 2025 indicating that approximately 44,680 motor vehicle fatalities occurred in the United States in 2024. This statistic reflects the persistent burden of high-velocity accidents, which frequently cause complex nerve injuries that require surgical repair.

Market Driver

Advancements in 3D-printed and bioresorbable conduit technologies are fundamentally reshaping the market by overcoming the limitations of traditional autografts, such as limited tissue availability and donor-site morbidity. Additive manufacturing innovations now allow for the creation of conduits with precise micro-architectures that mimic the natural extracellular matrix, improving axonal guidance and regeneration across nerve gaps. These modern scaffolds are designed to be fully bioresorbable, removing the need for secondary removal surgeries and lowering long-term inflammation. For instance, a study published in PubMed Central in August 2025 showed that a 3D-printed hydrogel conduit achieved functional motor nerve regeneration in murine models comparable to standard autografts, suggesting these synthetic options could become a viable standard of care.

The escalating incidence of traumatic peripheral nerve injuries serves as a primary catalyst for growth, driven by high-impact vehicular accidents, workplace hazards, and iatrogenic damage from complex surgeries. This rising burden necessitates reliable, off-the-shelf repair solutions to bridge nerve defects when tensionless repair is not possible. ResearchGate findings from December 2025 identified peri-operative peripheral nerve injury rates at 14.6 per 100,000 surgical admissions, highlighting the significant demand for effective regenerative interventions. This clinical need translates into financial growth for industry leaders; Axogen, Inc. reported in February 2025 that its full-year 2024 revenue rose 17.8% to $187.3 million, fueled by the increased adoption of its advanced nerve repair technologies.

Market Challenge

The growth of the global market is significantly impeded by the high cost of advanced conduit systems and restrictive reimbursement policies. Healthcare systems operating under tight budgets often prioritize cost containment, leading to a hesitation to adopt premium bioengineered implants when cheaper alternatives like direct sutures or autografts are available. This financial pressure is intensified in regions where insurance frameworks classify these devices as investigational or elective, denying adequate coverage and forcing hospitals or patients to absorb the costs, thereby limiting availability to a small fraction of the population.

This economic disparity severely restricts the widespread commercial adoption of off-the-shelf nerve repair solutions. Data from the American Society of Plastic Surgeons in 2024 indicated that the median total charge for a nerve conduit repair procedure was approximately $25,717, a figure substantially higher than standard primary repair techniques. Such elevated procedural expenses create a disincentive for mass adoption, effectively confining the market to well-funded institutions and preventing the industry from displacing conventional, less expensive treatment modalities on a global scale.

Market Trends

The market is shifting from passive nerve bridging to active biological repair through the incorporation of neurotrophic factors into conduit designs. Manufacturers are prioritizing the development of devices that biologically stimulate axonal regrowth to address the functional limitations of inert tubes in long-gap injuries. This move toward biologically active solutions is gaining commercial traction as payers recognize the long-term value of functional restoration over simple structural repair. Reflecting this trend, Axogen, Inc. reported in October 2025 that it had successfully expanded reimbursement access for its nerve repair portfolio to approximately 18.1 million covered lives in 2025, demonstrating the rising demand for advanced regenerative algorithms.

Concurrently, the emergence of hybrid natural-synthetic composite materials is optimizing implant efficacy by combining the mechanical durability of polymers with the biocompatibility of biological matrices. Unlike first-generation synthetics that often caused inflammation or pure biologics that lacked rigidity, these next-generation composites-such as hydrogel-reinforced extracellular matrices-offer a balanced microenvironment that supports cell adhesion while preventing collapse. This technological evolution is bolstering financial performance for key innovators; Axogen, Inc. announced in October 2025 that its third-quarter revenue reached $60.1 million, a 23.5% increase driven by the adoption of its advanced hybrid and biologic systems.

Key Market Players

  • Axogen Corporation
  • Axonics, Inc.
  • Cytograft Tissue Engineering
  • FibroGen, Inc.
  • Eton Bioscience Inc.
  • Kerimedical SA
  • Synaptive Medical Inc.
  • Stryker Corporation
  • Newrotex Ltd
  • Integra LifeSciences Corporation

Report Scope

In this report, the Global Artificial Nerve Conduits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Artificial Nerve Conduits Market, By Material

  • Synthetic
  • Biologic
  • Hybrid

Artificial Nerve Conduits Market, By Nerve

  • Contact Guidance
  • Channel Guidance
  • Microtopography Guidance

Artificial Nerve Conduits Market, By Electroactivity

  • Electroactive
  • Non-electroactive

Artificial Nerve Conduits Market, By Application

  • Peripheral Nerve Repair
  • Spinal Cord Injury Repair
  • Cranial Nerve Repair

Artificial Nerve Conduits Market, By End Use

  • Hospitals
  • Clinics
  • Research Institutes

Artificial Nerve Conduits Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Artificial Nerve Conduits Market.

Available Customizations:

Global Artificial Nerve Conduits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Artificial Nerve Conduits Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Material (Synthetic, Biologic, Hybrid)
    • 5.2.2. By Nerve (Contact Guidance, Channel Guidance, Microtopography Guidance)
    • 5.2.3. By Electroactivity (Electroactive, Non-electroactive)
    • 5.2.4. By Application (Peripheral Nerve Repair, Spinal Cord Injury Repair, Cranial Nerve Repair)
    • 5.2.5. By End Use (Hospitals, Clinics, Research Institutes)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America Artificial Nerve Conduits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Material
    • 6.2.2. By Nerve
    • 6.2.3. By Electroactivity
    • 6.2.4. By Application
    • 6.2.5. By End Use
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Artificial Nerve Conduits Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Material
        • 6.3.1.2.2. By Nerve
        • 6.3.1.2.3. By Electroactivity
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End Use
    • 6.3.2. Canada Artificial Nerve Conduits Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Material
        • 6.3.2.2.2. By Nerve
        • 6.3.2.2.3. By Electroactivity
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End Use
    • 6.3.3. Mexico Artificial Nerve Conduits Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Material
        • 6.3.3.2.2. By Nerve
        • 6.3.3.2.3. By Electroactivity
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End Use

7. Europe Artificial Nerve Conduits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Material
    • 7.2.2. By Nerve
    • 7.2.3. By Electroactivity
    • 7.2.4. By Application
    • 7.2.5. By End Use
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Artificial Nerve Conduits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Material
        • 7.3.1.2.2. By Nerve
        • 7.3.1.2.3. By Electroactivity
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End Use
    • 7.3.2. France Artificial Nerve Conduits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Material
        • 7.3.2.2.2. By Nerve
        • 7.3.2.2.3. By Electroactivity
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End Use
    • 7.3.3. United Kingdom Artificial Nerve Conduits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Material
        • 7.3.3.2.2. By Nerve
        • 7.3.3.2.3. By Electroactivity
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End Use
    • 7.3.4. Italy Artificial Nerve Conduits Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Material
        • 7.3.4.2.2. By Nerve
        • 7.3.4.2.3. By Electroactivity
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End Use
    • 7.3.5. Spain Artificial Nerve Conduits Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Material
        • 7.3.5.2.2. By Nerve
        • 7.3.5.2.3. By Electroactivity
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End Use

8. Asia Pacific Artificial Nerve Conduits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Material
    • 8.2.2. By Nerve
    • 8.2.3. By Electroactivity
    • 8.2.4. By Application
    • 8.2.5. By End Use
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Artificial Nerve Conduits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Material
        • 8.3.1.2.2. By Nerve
        • 8.3.1.2.3. By Electroactivity
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End Use
    • 8.3.2. India Artificial Nerve Conduits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Material
        • 8.3.2.2.2. By Nerve
        • 8.3.2.2.3. By Electroactivity
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End Use
    • 8.3.3. Japan Artificial Nerve Conduits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Material
        • 8.3.3.2.2. By Nerve
        • 8.3.3.2.3. By Electroactivity
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End Use
    • 8.3.4. South Korea Artificial Nerve Conduits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Material
        • 8.3.4.2.2. By Nerve
        • 8.3.4.2.3. By Electroactivity
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End Use
    • 8.3.5. Australia Artificial Nerve Conduits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Material
        • 8.3.5.2.2. By Nerve
        • 8.3.5.2.3. By Electroactivity
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End Use

9. Middle East & Africa Artificial Nerve Conduits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Material
    • 9.2.2. By Nerve
    • 9.2.3. By Electroactivity
    • 9.2.4. By Application
    • 9.2.5. By End Use
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Artificial Nerve Conduits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Material
        • 9.3.1.2.2. By Nerve
        • 9.3.1.2.3. By Electroactivity
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End Use
    • 9.3.2. UAE Artificial Nerve Conduits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Material
        • 9.3.2.2.2. By Nerve
        • 9.3.2.2.3. By Electroactivity
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End Use
    • 9.3.3. South Africa Artificial Nerve Conduits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Material
        • 9.3.3.2.2. By Nerve
        • 9.3.3.2.3. By Electroactivity
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End Use

10. South America Artificial Nerve Conduits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Material
    • 10.2.2. By Nerve
    • 10.2.3. By Electroactivity
    • 10.2.4. By Application
    • 10.2.5. By End Use
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Artificial Nerve Conduits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Material
        • 10.3.1.2.2. By Nerve
        • 10.3.1.2.3. By Electroactivity
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End Use
    • 10.3.2. Colombia Artificial Nerve Conduits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Material
        • 10.3.2.2.2. By Nerve
        • 10.3.2.2.3. By Electroactivity
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End Use
    • 10.3.3. Argentina Artificial Nerve Conduits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Material
        • 10.3.3.2.2. By Nerve
        • 10.3.3.2.3. By Electroactivity
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Artificial Nerve Conduits Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Axogen Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Axonics, Inc.
  • 15.3. Cytograft Tissue Engineering
  • 15.4. FibroGen, Inc.
  • 15.5. Eton Bioscience Inc.
  • 15.6. Kerimedical SA
  • 15.7. Synaptive Medical Inc.
  • 15.8. Stryker Corporation
  • 15.9. Newrotex Ltd
  • 15.10. Integra LifeSciences Corporation

16. Strategic Recommendations

17. About Us & Disclaimer